Company / PP&E per Share
Halozyme PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.36
FY2025
5-year range
$0.05 / $0.36
FY2021-FY2025
Trend
+12.0%
vs FY2024
Sector context
#65 of 191
Health Care
What the data says
At $0.36, Halozyme's pp&e per share ranks #65 of 191 in the Health Care sector. PP&E per Share has increased for 4 consecutive years, from $0.05 in FY2021 to $0.36 in FY2025.
Based on SEC 10-K filings.
0.36 in FY2025 with a 5-year CAGR of +36.0%.
Improved from $0.28 to $0.36 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +12.2%
- 5-Year CAGR
- +36.0%
- 10-Year CAGR
- -
Sector benchmark
#65 of 191 in Health CareTop 34% of 191This company $0.36 Sector average $18.90
▼
-98.1% below sector average
Key checks
Key Insights
- Halozyme's pp&e per share has grown for 4 consecutive years.
- In FY2025, pp&e per share increased 12.0% year-over-year.
- Ranks #65 out of 191 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 47.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 118.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.36 | +12.0% |
| FY2024 | $0.32 | +14.3% |
| FY2023 | $0.28 | +10.4% |
| FY2022 | $0.26 | +407.6% |
| FY2021 | $0.05 | -35.1% |
| FY2020 | $0.08 | +3.3% |
| FY2019 | $0.08 | +43.5% |
| FY2018 | $0.05 | +92.3% |
| FY2017 | $0.03 | -18.3% |
| FY2016 | $0.03 | +6.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026